Page last updated: 2024-09-05

phosphatidylcholines and Cardiotoxicity

phosphatidylcholines has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bax, JJ; Broeyer, FJ; Bruning, T; Burggraaf, J; Cohen, AF; de Jongh, F; de Kam, ML; Mituzhima, Y; Osanto, S; Ritsema van Eck, HJ; Suzuki, J; Tanis, BC; van Slooten, H1

Trials

1 trial(s) available for phosphatidylcholines and Cardiotoxicity

ArticleYear
Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients.
    British journal of clinical pharmacology, 2014, Volume: 78, Issue:5

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Cardiotonic Agents; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Echocardiography; Electrocardiography; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Middle Aged; Natriuretic Peptide, Brain; Netherlands; Peptide Fragments; Phosphatidylcholines; Superoxide Dismutase; Young Adult

2014